2seventy bio (TSVT) Reports Preliminary Full-Year U.S. Abecma Sales
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
February 6, 2025 7:03 AM EST$242 million in U.S. Abecma sales in 2024
Approximately $184 million of cash, cash equivalents and marketable securities as of December 31, 2024
Net cash burn of $9 million in the fourth quarter of 2024; path to quarterly breakeven by the end of 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- 2seventy bio, Inc. (Nasdaq:... More
